High prevalence and increasing incidence of Addison's disease in western Norway
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Summary: objective Estimates of the prevalence of Addison's disease in Caucasians have varied from 39 to 117 per million. We have carried out an epidemiological study to obtain a confident point prevalence estimate in the Norwegian population for the end of 1999, and to find out whether the incidence is changing. patients and methods The patients were identified by a search through registers of 10 hospitals and consultant endocrinologists serving a population of 916 000. The completeness of the list was tested by a survey of general practitioners in one district, and by the member list of the local Addison Association in another district. results We identified 128 patients with Addison's disease (59 men and 69 women), yielding a prevalence of 140 per million. Recorded mean incidence in the past decade was 0·62 per 100 000 per year. Fifty‐one patients (40%) had concomitant endocrine diseases. The aetiology was almost exclusively idiopathic or autoimmune. conclusions We found a higher prevalence of Addison's disease in western Norway than has previously been reported anywhere. Our findings support the hypothesis of a rising incidence of autoimmune adrenal insufficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucocorticoid replacement therapy: are patients over treated and does it matter?
Peacey, S. R., Guo, C., Robinson, A. M., Price, A., Giles, M. A., Eastell, R., & Weetman, A. P. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.780907.x · Cited by 205
An assessment of optimal hydrocortisone replacement therapy
Howlett, T. A. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1340955.x · Cited by 169 · cited 2×
“There are concerns about the effects of excess glucocorticoid replacement (Monson, 1997; Jeffcoate, 1999), with respect to osteoporosis (Howlett, 1997; Peacey et al., 1997; Braatvedt et al., 1999) and metabolic effects (al-Shoumer et al., 1995).”
Background
Cited by
The epidemiology of autoimmune diseases
Cooper, G. S., & Stroehla, B. C. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(03)00006-5 · Cited by 880
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819
Cooper, G. S., Bynum, M. L. K., & Somers, E. C. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.008 · Cited by 736
Charmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Premature Mortality in Patients with Addison’s Disease: A Population-Based Study
Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0076 · Cited by 490
“We were not able to determine the proportion of type 1 and 2 DM in the national cohort, but others have demonstrated an increased frequency of type 1 DM among patients with Addison’s disease (3).”
BackgroundResultInfluential
Metadata
- Authors
- Løvås, K., & Husebye, E. S.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2002-06
- Volume
- 56
- Issue
- 6
- Pages
- 787-791
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2035623886
- Cited by
- 222
- References
- 2
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High prevalence and increasing incidence of Addison's disease in western Norway. https://app.cochat.ai/papers/10.1046/j.1365-2265.2002.t01-1-01552.x
- The paper
- Løvås, K., & Husebye, E. S. (2002). High prevalence and increasing incidence of Addison's disease in western Norway. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2002.t01-1-01552.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.